Issue 27, 2022

Total synthesis, structure revision and cytotoxic activity of Sch 53825 and its derivatives

Abstract

The first total synthesis of Sch 53825 (14) was achieved in 12 steps from 5-hydroxy-1-tetralone in 16% overall yield through N-benzyl cinchoninium chloride-catalyzed asymmetric epoxidation and a Mitsunobu reaction as the key steps. On this basis, the synthesis of palmarumycin B6 was improved using the same raw material with 6 steps and 32% overall yield. Also, three new analogues with two chlorine atoms were synthesized. Their structures were characterized by 1H, 13C NMR, HR-ESI-MS and X-ray diffraction data. The structure of natural Sch 53825 was revised as an epimer of compound 1 with the anti-hydroxy epoxide at C-4. Their cytotoxic activities against several tumor cell lines (HCT116, U251, BGC823, Huh-7 and PC9) showed that compound 11 exhibited excellent cytotoxicity against above mentioned cancer cell lines with IC50 < 0.5 μM.

Graphical abstract: Total synthesis, structure revision and cytotoxic activity of Sch 53825 and its derivatives

Supplementary files

Article information

Article type
Paper
Submitted
07 May 2022
Accepted
01 Jun 2022
First published
14 Jun 2022
This article is Open Access
Creative Commons BY-NC license

RSC Adv., 2022,12, 17629-17636

Total synthesis, structure revision and cytotoxic activity of Sch 53825 and its derivatives

L. Xu, H. Ma, X. An, Y. Li, Q. Zhang, X. Liu and M. Wang, RSC Adv., 2022, 12, 17629 DOI: 10.1039/D2RA02898K

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements